February 17, 2015

The Food and Drug Administration last week issued five draft documents related to drug compounding and repackaging that will help entities comply with important public health provisions.

February 17, 2015

Lupin and Celon Pharma announced Tuesday that they have entered into a definitive agreement under which the companies will jointly develop a fluticasone/salmeterol dry powder inhaler product which is a generic version of GlaxoSmithKline's Advair Diskus.

February 13, 2015

In response to the New York Attorney General’s recent recall of herbal supplements from four major retailers, the Council for Responsible Nutrition has assembled a microsite for consumers.

February 13, 2015

During this webcast, ECRM lead business intelligence analyst Tanie Andraos discusses findings from ECRM Data's Ad Comparisons research covering the cough-cold category, highlighting trends in retailer and brand circular strategies and tactics.

February 12, 2015

Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., on Thursday introduced companion legislation to House bill H.R. 471.

 

February 12, 2015

Procter & Gamble’s Crest has unveiled its latest advancement in oral care with Crest Pro-Health [HD], a new two-step system formulated for deep cleaning and advanced whitening that promises to go beyond your ordinary toothpaste.

February 12, 2015

The House Energy and Commerce Committee passed legislation to help curb prescription drug diversion and abuse and protect patients in need of medication.

February 12, 2015

As many as 53% of consumers feel it's not so easy to understand their personal health information. 

 

February 12, 2015

Northern Ireland is tapping into retail pharmacists as an integral health resource.

February 12, 2015

In honor of American Heart Month, Omron Healthcare and AliveCor are empowering people to take charge of their health through precise technology. 

February 11, 2015

Skin care brand derma e has announced the launch of its new Scalp Relief Shampoo and Conditioner.

February 11, 2015

Iron supplementation found to reduce time of recovery for blood donors, according to a National Institutes of Health-funded study. 

February 11, 2015

Sam's Club will be showing its love to its customers this Valentine's Day with the offering of a free heart health screening.

February 10, 2015

As part of its ongoing exploration of how pharmacists can engage in interdisciplinary efforts to promote oral health, the American Pharmacists Association Foundation has teamed up with America’s ToothFairy: National Children’s Oral Health Foundation.

February 10, 2015

China Jo-Jo Drugstores entered into a service agreement with Alibaba Health Information Technology to utilize its electronic prescription platform. 

February 10, 2015

The Wall Street Journal on Sunday reported that DexCom, a medical-device maker, is developing a diabetes glucose monitoring app to be compatible with the Apple Watch.

February 10, 2015

GNC on Monday announced that it refuted the claims made by the New York State Attorney General in his Feb. 2 letter.

February 10, 2015

From Jan. 1 to Feb. 6, 2015, 121 people from 17 states and Washington D.C. were reported to have measles.

February 10, 2015

As many as 85% of working women are focused on maintaining a healthy lifestyle or losing weight.

February 10, 2015

PricewaterhouseCoopers released a new spotlight on the dangers of antimicrobial resistance.

 

February 9, 2015

Bayer HealthCare on Monday announced the launch of the ProHeart Path Tool. 

February 9, 2015

Under new bipartisan legislation, seniors would have more convenient access to discounted or "preferred" co-pays for prescription drugs at their pharmacy of choice.

February 9, 2015

Daiichi Sankyo on Monday announced that its Savaysa (edoxaban) tablets are now available in pharmacies across the United States. The drug was granted approval from the Food and Drug Administration on Jan. 8 and is used to reduce the risk of stroke and systemic embolism in patients who have a non-valvular atrial fibrillation, as well as for the treatment of deep vein thrombosis and pulmonary embolism, the company said.

February 9, 2015

Onco360 on Monday announced that it has been selected by Pfizer as a limited-distribution pharmacy network participant for Ibrance (palbociclib), Pfizer’s recently approved product for certain breast cancers.